FCIM
LLY icon

Fairview Capital Investment Management’s Eli Lilly LLY Stock Holding History

Fairview Capital Investment Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$647K Buy
539
+255
+90% +$261K 0.03% 129
2026
Q1 		$261K Sell
284
-47
-14% -$47.6K 0.01% 173
2025
Q4 		$356K Buy
331
+5
+2% +$4.78K 0.02% 138
2025
Q3 		$249K Hold
326
– – 0.01% 155
2025
Q2 		$254K Sell
326
-80
-20% -$62.2K 0.01% 146
2025
Q1 		$335K Sell
406
-44
-10% -$36.6K 0.02% 131
2024
Q4 		$347K Sell
450
-124
-22% -$103K 0.02% 133
2024
Q3 		$509K Buy
574
+221
+63% +$199K 0.03% 110
2024
Q2 		$320K Hold
353
– – 0.02% 122
2024
Q1 		$275K Buy
+353
New +$251K 0.02% 137
2021
Q3 		– Sell
-1,153
Closed -$264K – 129
2021
Q2 		$264K Hold
1,153
– – 0.02% 112
2021
Q1 		$215K Buy
+1,153
New +$226K 0.01% 150

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fairview Capital Investment Management's LLY Position: Q2 2026 in Review

Fairview Capital Investment Management increased its Eli Lilly (LLY) stake by 90% in Q2 2026, buying an estimated $261K and bringing the position to 539 shares worth $647K. The position accounts for 0.03% of the portfolio, ranked #129.

Fairview Capital Investment Management first reported a position in LLY in Q1 2021 and has held it in 12 quarters since. 4,647 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Fairview Capital Investment Management held 539 shares of Eli Lilly worth $647K as of Q2 2026.
  • Fairview Capital Investment Management bought 255 Eli Lilly shares in Q2 2026, an estimated $261K.
  • Eli Lilly made up 0.03% of Fairview Capital Investment Management's portfolio in Q2 2026, its #129 holding.
  • Fairview Capital Investment Management first reported a position in Eli Lilly in Q1 2021 and has held it in 12 quarters since.
  • 4,647 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Fairview Capital Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.